Free Access
Med Sci (Paris)
Volume 23, Number 4, Avril 2007
Page(s) 353 - 355
Section Nouvelles
Published online 15 April 2007
  1. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006; 441 : 431–6. [Google Scholar]
  2. Weil R, Israël A. Deciphering the pathway from the TCR to NF-kappaB. Cell Death Differ 2006; 13 : 826–33. [Google Scholar]
  3. Ruefli-Brasse AA, Lee WP, Hurst S, Dixit VM. Rip2 participates in Bcl10 signaling and T-cell receptor-mediated NF-kappa B activation. J Biol Chem 2003; 279 : 1570–74. [Google Scholar]
  4. Ishiguro K, Ando T, Goto H, Xavier R. Bcl10 is phosphorylated on Ser138 by Ca2+/calmodulin-dependent protein kinase II. Mol Immunol 2007; 44 : 2105–10. [Google Scholar]
  5. Wegener E, Oeckinghaus A, Papadopoulou N, et al. Essential role for IkappaB kinase beta in remodeling Carma1-Bcl10-MALT1 complexes upon T cell activation. Mol Cell 2006; 23 : 13–23. [Google Scholar]
  6. Scharschmidt E, Wegener E, Heissmeyer V, et al. Degradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signaling. Mol Cell Biol 2004; 24 : 3860–73. [Google Scholar]
  7. Hu S, Alcivar A, Qu L, et al. CIAP2 inhibits antigen receptor signaling by targeting Bcl10 for degradation. Cell Cycle 2006; 5 : 1438–42. [Google Scholar]
  8. Lobry C, Lopez T, Israel A, Weil R. Negative feedback loop in T cell activation through IkappaB kinase-induced phosphorylation and degradation of Bcl10. Proc Natl Acad Sci USA 2007; 104 : 908–13. [Google Scholar]
  9. Liu Y, Dong W, Chen L, et al. Characterization of Bcl10 as a potential transcriptional activator that interacts with general transcription factor TFIIB. Biochem Biophys Res Commun 2004; 320 : 1–6. [Google Scholar]
  10. Lee SH, Shin MS, Kim HS, et al. Point mutations and deletions of the Bcl10 gene in solid tumors and malignant lymphomas. Cancer Res 1999; 59 : 5674–7. [Google Scholar]
  11. Willis TG, Jadayel DM, Du MQ, et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 1999; 96 : 35–45. [Google Scholar]
  12. Wu G, Xu G, Schulman BA, et al. Structure of beta-TrCP-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCFbeta-TrCP1 ubiquitin ligase. Mol Cell 2003; 11 : 1445–56. [Google Scholar]
  13. Chan EF, Gat U, McNiff JM, Fuchs E. A common human skin tumour is caused by activating mutations in beta-catenin. Nat Genet 1999; 21 : 410–3. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.